GordonMD Global Investments logo

GordonMD Global Investments

North America, California, United States, Beverly Hills

Description

GordonMD Global Investments focused on investments in private and publicly traded global growth and innovative biopharma companies.

Investor Profile

GordonMD Global Investments has made 10 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (50%)
  • Post Ipo Equity (20%)
  • Series A (20%)
  • Seed (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Life Science
  • Pharmaceutical
  • Genetics
  • Biopharma
  • Medical
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GordonMD Global Investments frequently co-invest with?

Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
RTW Investments
North America, New York, United States, New York
Co-Investments: 2
Frazier Life Sciences
North America, California, United States, Menlo Park
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
CAM Capital
North America, New York, United States, New York
Co-Investments: 2
EPIQ Capital Group
North America, California, United States, San Francisco
Co-Investments: 3
DCVC Bio
North America, California, United States, San Francisco
Co-Investments: 2
Crinetics Pharmaceuticals
North America, California, United States, San Diego
Co-Investments: 2
Invus
North America, New York, United States, New York
Co-Investments: 3

What are some of recent deals done by GordonMD Global Investments?

Amlogenyx

Somerville, Massachusetts, United States

Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease.

BiotechnologyGeneticsTherapeutics
SeedAug 2, 2024
Amount Raised: $14,000,000
Crinetics Pharmaceuticals

San Diego, California, United States

Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityFeb 28, 2024
Amount Raised: $350,000,000
Radionetics Oncology

California City, California, United States

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Health CareMedicalOncologyPharmaceuticalTherapeutics
Series AJan 3, 2024
Amount Raised: $52,500,000
Taysha Gene Therapies

Dallas, Texas, United States

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

BiotechnologyGeneticsLife Science
Post Ipo EquityAug 14, 2023
Amount Raised: $150,000,000
Radionetics Oncology

California City, California, United States

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Health CareMedicalOncologyPharmaceuticalTherapeutics
Series AAug 14, 2023
Amount Raised: $52,500,000
Kyverna Therapeutics

Berkeley, California, United States

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

BiotechnologyLife ScienceTherapeutics
Series BAug 3, 2023
Amount Raised: $60,000,000
Flare Therapeutics

Cambridge, Massachusetts, United States

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

BiopharmaBiotechnologyHealth CareLife Science
Series BMar 22, 2023
Amount Raised: $123,000,000
Spotlight Therapeutics

Hayward, California, United States

Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BMar 22, 2022
Amount Raised: $36,500,000
SalioGen Therapeutics

Burlington, Massachusetts, United States

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

BiotechnologyGeneticsLife ScienceTherapeutics
Series BJan 5, 2022
Amount Raised: $115,000,000
Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics
Series BNov 3, 2021
Amount Raised: $75,000,000